<?xml version="1.0" encoding="UTF-8"?>
<p>In this study we included different Flavivirus: JEV Laos strain (genotype 1; GenBank 
 <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CNS769_Laos_2009" xmlns:xlink="http://www.w3.org/1999/xlink">CNS769_Laos_2009</ext-link>; kindly provided by Prof. Remi Charrel, Aix-Marseille Université, Marseille, France), WNV NY99 (GenBank 
 <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="DQ211652.1" xmlns:xlink="http://www.w3.org/1999/xlink">DQ211652.1</ext-link>; kindly donated by Prof. Martin Groschup, Friedrich-Loeffler-Institute, Germany), USUV SAAR-1776 strain (GenBank 
 <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="AY453412" xmlns:xlink="http://www.w3.org/1999/xlink">AY453412</ext-link>; kindly provided by Prof. Richard Hoop, University of Zürich, Zürich, Switzerland); DENV-3 VN32/96 strain, (serotype 3, GenBank 
 <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="EU482459" xmlns:xlink="http://www.w3.org/1999/xlink">EU482459</ext-link>, kindly provided by Dr. Katja Fink, Singapore Immunology Network, SIgN, Singapore), ZIKV strain PR-2015 (Asian lineage, PRVABC59; GenBank 
 <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="KX377337" xmlns:xlink="http://www.w3.org/1999/xlink">KX377337</ext-link>; obtained from Public Health England PHE); SPOV strain SM-6 V-1s (South Africa, GenBank 
 <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="DQ859064" xmlns:xlink="http://www.w3.org/1999/xlink">DQ 859064</ext-link>.1 Originator: Oxford Institute of Virology, provided by EVAg, Marseille, France) and WESSV strain SAH-177 99871-2, passage 8 (South Africa, GenBank 
 <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="EU707555.1" xmlns:xlink="http://www.w3.org/1999/xlink">EU707555.1</ext-link>, Originator: UTMB collection, provided by EVAg, Marseille, France). All Flaviviruses were propagated in 
 <italic>A. albopictus</italic> C6/36 cells (ATCC
 <sup>®</sup> CRL-1660™) in MEM (Gibco, Lucerne, Switzerland) supplemented with sodium pyruvate at 100 mM (Gibco), non-essential amino acids (MEM NEAA; Gibco) and 2% fetal bovine serum (FBS) (
 <italic>v/v</italic>) (Biochrome, Bioswisstec AG, Schaffhausen, Switzerland) at 28°C and in 5% CO
 <sub>2</sub> atmosphere conditions. Virus titrations were obtained using C6/36 cells as previously described (Ricklin et al., 
 <xref rid="B42" ref-type="bibr">2016</xref>). Infected cells were detected using immunoperoxidase monolayer assay (IPMA) with the anti-flavivirus E mAb 4G2 (ATCC, HB-112™). Titers were calculated and expressed as 50% tissue culture infective dose per ml (TCID
 <sub>50</sub>/ml).
</p>
